Format
Sort by
Items per page

Send to

Choose Destination

Best matches for DHEA in women:

Search results

Items: 1 to 20 of 4004

1.

Dehydroepiandrosterone and cortisol as markers of HPA axis dysregulation in women with low sexual desire.

Basson R, O'Loughlin JI, Weinberg J, Young AH, Bodnar T, Brotto LA.

Psychoneuroendocrinology. 2019 Mar 8;104:259-268. doi: 10.1016/j.psyneuen.2019.03.001. [Epub ahead of print]

PMID:
30909007
2.

Involvement of serum dehydroepiandrosterone sulfate in erythropoietic activity.

Harada K, Hanayama Y, Obika M, Itoshima K, Okada K, Otsuka F.

Aging Male. 2019 Mar 23:1-8. doi: 10.1080/13685538.2019.1592151. [Epub ahead of print]

PMID:
30905228
3.

Association between locomotive syndrome and blood parameters in Japanese middle-aged and elderly individuals: a cross-sectional study.

Yoshihara T, Ozaki H, Nakagata T, Natsume T, Kitada T, Ishihara Y, Sawada S, Ishibashi M, Kobayashi H, Machida S, Naito H.

BMC Musculoskelet Disord. 2019 Mar 14;20(1):104. doi: 10.1186/s12891-019-2480-9.

4.

Associations between major dietary patterns and testicular function in a population-based cohort of young men: results from the Western Australian Pregnancy Cohort (Raine) Study.

Ognjenovic M, Ambrosini GL, Malacova E, Doherty DA, Oddy WH, Handelsman DJ, McLachlan R, Dickinson J, Hart RJ.

Andrology. 2019 Mar 10. doi: 10.1111/andr.12598. [Epub ahead of print] Review.

PMID:
30854803
5.

Comparison of Two Statistical Methods to Determine Normal Range of Androgen Hormones: K-Means Cluster Analysis and Receiver Operating Characteristic Curve.

Ramezani-Tehrani F, Rahmani K, Moradi A, Montazeri SA, Bidhendi-Yarandi R, Darabi F.

J Family Reprod Health. 2018 Jun;12(2):96-102.

6.

Female primary and secondary psychopathic variants show distinct endocrine and psychophysiological profiles.

Goulter N, Kimonis ER, Denson TF, Begg DP.

Psychoneuroendocrinology. 2019 Feb 13;104:7-17. doi: 10.1016/j.psyneuen.2019.02.011. [Epub ahead of print]

PMID:
30784904
7.

Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome.

Wang M, Zhao D, Xu L, Guo W, Nie L, Lei Y, Long Y, Liu M, Wang Y, Zhang X, Zhang L, Li H, Zhang J, Yuan D, Yue L.

Metabolism. 2019 May;94:47-58. doi: 10.1016/j.metabol.2019.02.002. Epub 2019 Feb 12.

PMID:
30768966
8.

11-Oxygenated C19 Steroids Do Not Decline with Age in Women.

Nanba AT, Rege J, Ren J, Auchus RJ, Rainey WE, Turcu AF.

J Clin Endocrinol Metab. 2019 Feb 8. doi: 10.1210/jc.2018-02527. [Epub ahead of print]

PMID:
30753518
9.

The effects of cortisol and adrenal androgen on bone mass in Asians with and without subclinical hypercortisolism.

Ahn SH, Kim JH, Cho YY, Suh S, Kim BJ, Hong S, Lee SH, Koh JM, Song KH.

Osteoporos Int. 2019 Feb 4. doi: 10.1007/s00198-019-04871-5. [Epub ahead of print]

PMID:
30719548
10.

The Possibilities of Using Chromium Salts as an Agent Supporting Treatment of Polycystic Ovary Syndrome.

Piotrowska A, Pilch W, Czerwińska-Ledwig O, Zuziak R, Siwek A, Wolak M, Nowak G.

Biol Trace Elem Res. 2019 Feb 4. doi: 10.1007/s12011-019-1654-5. [Epub ahead of print] Review.

PMID:
30715682
11.

The Effect of Statins on Levels of Dehydroepiandrosterone (DHEA) in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.

Yang S, Gu YY, Jing F, Yu CX, Guan QB.

Med Sci Monit. 2019 Jan 20;25:590-597. doi: 10.12659/MSM.914128.

12.

Exploring immunomodulation by endocrine changes in Lady Windermere syndrome.

Holt MR, Miles JJ, Inder WJ, Thomson RM.

Clin Exp Immunol. 2019 Apr;196(1):28-38. doi: 10.1111/cei.13265. Epub 2019 Feb 27. Review.

PMID:
30697704
13.

Functional and endocrine-metabolic oligomenorrhea: proposal of a new diagnostic assessment tool for differential diagnosis in adolescence.

Baggio S, Di Paola R, Zaffagnini S, Fino S, Raffaelli R, Franchi M.

J Pediatr Endocrinol Metab. 2019 Feb 25;32(2):135-142. doi: 10.1515/jpem-2018-0351.

PMID:
30685743
14.

Risk markers of reproductive loss in women with hyperandrogenism.

Semeniuk LM, Likhachov VK, Yuzvenko TY, Dobrovolska LМ, Makarov OG.

Wiad Lek. 2018;71(8):1550-1553.

PMID:
30684339
15.

A rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman.

Zhou WB, Chen N, Li CJ.

BMC Endocr Disord. 2019 Jan 23;19(1):14. doi: 10.1186/s12902-019-0342-y.

16.

Identification of the metabolic fingerprints in women with polycystic ovary syndrome using the multiplatform metabolomics technique.

Buszewska-Forajta M, Rachoń D, Stefaniak A, Wawrzyniak R, Konieczna A, Kowalewska A, Markuszewski MJ.

J Steroid Biochem Mol Biol. 2019 Feb;186:176-184. doi: 10.1016/j.jsbmb.2018.10.012. Epub 2018 Oct 27.

PMID:
30670174
17.

Relationships Between Biochemical Markers of Hyperandrogenism and Metabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.

Amiri M, Tehrani FR, Bidhendi-Yarandi R, Behboudi-Gandevani S, Azizi F, Carmina E.

Horm Metab Res. 2019 Jan;51(1):22-34. doi: 10.1055/a-0806-8281. Epub 2019 Jan 16.

PMID:
30650457
18.

Effect of preconceptional DHEA treatment on in vitro fertilization outcome in poor ovarian respond women: study protocol for a randomized controlled trial.

Wang W, Liu H, Li J, Wei D, Zhang J, Wang J, Ma J, Shi Y, Chen ZJ.

Trials. 2019 Jan 15;20(1):50. doi: 10.1186/s13063-018-3146-x.

19.

Gender differences in subjective stress and neuroendocrine response to a stress task among individuals with opioid dependence: A pilot study.

Gilmore AK, Guille C, Baker NL, Brady KT, Hahn CK, Davis CM, McCauley JL, Back SE.

Addict Behav. 2019 Jan 5;92:148-154. doi: 10.1016/j.addbeh.2018.12.022. [Epub ahead of print]

PMID:
30640146
20.

Nontargeted metabolomic analysis of skeletal muscle in a dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome.

Shen Q, Bi H, Yu F, Fan L, Zhu M, Jia X, Kang J.

Mol Reprod Dev. 2019 Jan 11. doi: 10.1002/mrd.23111. [Epub ahead of print]

PMID:
30633842

Supplemental Content

Loading ...
Support Center